Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12885924 | 1.00 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL12310224 | 1.00 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL12898753 | 0.89 | MAPT (0.56) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL12898087 | 0.89 | MAPT (0.56) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL6995632 | 0.89 | MAPT (0.56) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| Hydrochloric Acid SCHEMBL28542420 | 0.88 | MAPT (0.54) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| Hydrochloric Acid SCHEMBL28542417 | 0.88 | MAPT (0.54) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL12633299 | 0.86 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2HTTKDM4ECYP2C19 | |
| SCHEMBL25700853 | 0.83 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2HTTHPGDKDM4E | |
| SCHEMBL12881570 | 0.83 | ALDH1A1 (0.61) | ALDH1A1SMN1; SMN2HTTKDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2617779-B1 | Low odor environmentally-friendly nano-pigment inkjet ink composition | JETBEST CORP (TW) | 2014-11-05 | — | — | EP | claimed |
| US-8710118-B2 | Nano-pigment inkjet ink composition that has a low odor and is environmentally-friendly | JETBEST CORPORATION (TW) | 2014-04-29 | — | — | US | claimed |
| CN-103242694-A | Low-odor environment-friendly nano pigment ink-jet ink composition | JETBEST CORP | 2013-08-14 | — | — | CN | claimed |
| US-20130190421-A1 | LOW ODOR ENVIRONMENTALLY-FRIENDLY NANO-PIGMENT INKJET INK COMPOSITION | JETBEST CORPORATION (TW) | 2013-07-25 | — | — | US | claimed |
| EP-2617779-A1 | Low odor environmentally-friendly nano-pigment inkjet ink composition | JETBEST Corporation (TW) | 2013-07-24 | — | — | EP | claimed |
| US-20240132270-A1 | Systems and Methods of Storing 1,1-Disubstituted Alkene Compositions | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-04-25 | — | — | US | disclosed |
| CN-117551088-A | Green preparation process of high-purity tipedidine hydrochloride | 常州贝迪佳尔生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| EP-3351570-B1 | MODIFIED AND CONJUGATED DIENE-BASED POLYMER AND METHOD FOR PREPARING IT | LG CHEMICAL LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| CN-115232109-A | PD-1/PD-L1 small molecule inhibitor and application thereof in medicines | 广东东阳光药业有限公司 | 2022-10-25 | — | — | CN | disclosed |
| WO-2022168880-A1 | SYSTEMS AND METHODS OF STORING 1,1-DISUBSTITUTED ALKENE COMPOSITIONS | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-08-11 | — | — | WO | disclosed |
| US-20220153932-A1 | PREPOLYMERS OF 1,1-DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | SIRRUS INC (US) | 2022-05-19 | — | — | US | disclosed |
| US-20220112151-A1 | COMPOSITIONS OF DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | SIRRUS INC (US) | 2022-04-14 | — | — | US | disclosed |
| US-5206240-A | Antiarrhythmia agents | MERCK & CO., INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-5102890-A | Anxiolytic agents | RHONE-POULENC SANTE (FR) | 1992-04-07 | — | — | US | disclosed |
| CN-1053613-A | Nitrogen-containing spiro ring | MERCK & CO INC (US) | 1991-08-07 | — | — | CN | disclosed |
| EP-0431943-A2 | Nitrogen-containing spirocycles | MERCK & CO. INC. (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0328585-A1 | METABOLICALLY ACCEPTABLE POLYISOCYANATE ADHESIVES | BIORESEARCH INC. (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4829099-A | SURGERY, POLYISOCYANATES, POLYISOTHIOCYANATES | BIORESEARCH, INC. (US) | 1989-05-09 | — | — | US | disclosed |
| EP-0274259-A2 | New renin-inhibitory oligopeptides, their preparaton and their use | Sankyo Company Limited (JP) | 1988-07-13 | — | — | EP | disclosed |
| EP-0239309-A2 | Oxadiazoles useful in the treatment of senile dementia | MERCK SHARP & DOHME LTD. (GB) | 1987-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112151-A1 | COMPOSITIONS OF DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | PARG, PARN, LIG1 | ALDH1A1 274/4885SMN1; SMN2 2910/4885HTT 2049/4885 |
| US-20220153932-A1 | PREPOLYMERS OF 1,1-DICARBONYL SUBSTITUTED-1-ALKENE, METHODS TO MAKE THEM, POLYMERS MADE FROM THEM AND METHODS TO MAKE THE POLYMER | PLOD1, COL1A1, PLOD2 | ALDH1A1 313/4885SMN1; SMN2 2900/4885HTT 305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.